
    
      OBJECTIVES: I. Determine the toxicity and response to intensive chemotherapy followed by
      autologous peripheral blood stem cell transplantation in patients with Hodgkin's disease or
      non-Hodgkin's lymphoma who have received prior chemotherapy and/or radiotherapy.

      OUTLINE: Patients receive oral busulfan every 6 hours on days -9 to -6 and cyclophosphamide
      IV over 2 hours on days -5 to -2. Autologous peripheral blood stem cells are reinfused on day
      0. Patients are followed monthly for 1 year.

      PROJECTED ACCRUAL: Not specified
    
  